ENDOGEN ApS: Financial statements 2016
CVR: 29813337
Source: annual report 2016, Danish Business Authority
27/10/2015 – 26/10/2016
ENDOGEN ApS (CVR 29813337) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -13,184 and a net result of DKK -13,532 compared with DKK -16,471 the year before. Equity in the 2016 report amounted to DKK 42,590. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -13,184
- Profit/Loss
- DKK -13,532
- Equity
- DKK 42,590
- Total Assets
- DKK 42,590
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 0 | -13 t. | -14 t. | 43 t. | - |
| 2015 | 19 t. | -16 t. | -16 t. | 56 t. | - |
| 2014 | 19 t. | -36 t. | -37 t. | 70 t. | - |
| 2013 | 0 | -14 t. | -14 t. | 107 t. | - |
| 2012 | 0 | -990 | -1 t. | 121 t. | - |
Find more companies like ENDOGEN ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
ENDOGEN ApS has published its annual report for 2015. Revenue came to DKK 18,574, and the net result was DKK -16,471.
About ENDOGEN ApS
ENDOGEN ApS is a Danish company of the type Anpartsselskab based in Aarhus C, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Simon Glerup Pedersen. The company is owned by KOLLISION ApS, Camilla Gustafsen Consulting ApS and Simon Glerup Consulting ApS. In 2025, the company reported a gross profit of DKK 113,212 and a net result of DKK -79,499 compared with DKK -22,939 the year before. Equity in the 2025 report amounted to DKK -82,428.